Annual long term liabilities:
$334.30M-$75.90M(-18.50%)Summary
- As of today (September 16, 2025), TVTX annual total long term liabilities is $334.30 million, with the most recent change of -$75.90 million (-18.50%) on December 31, 2024.
- During the last 3 years, TVTX annual long term liabilities has fallen by -$16.14 million (-4.60%).
- TVTX annual long term liabilities is now -31.44% below its all-time high of $487.57 million, reached on December 31, 2022.
Performance
TVTX Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$333.02M-$497.00K(-0.15%)Summary
- As of today (September 16, 2025), TVTX quarterly total long term liabilities is $333.02 million, with the most recent change of -$497.00 thousand (-0.15%) on June 30, 2025.
- Over the past year, TVTX quarterly long term liabilities has dropped by -$81.68 million (-19.70%).
- TVTX quarterly long term liabilities is now -33.50% below its all-time high of $500.79 million, reached on March 31, 2022.
Performance
TVTX quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
TVTX Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.5% | -19.7% |
| 3 y3 years | -4.6% | -33.2% |
| 5 y5 years | - | +14.8% |
TVTX Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.4% | at low | -33.2% | at low |
| 5 y | 5-year | -31.4% | +10.1% | -33.5% | +14.8% |
| alltime | all time | -31.4% | >+9999.0% | -33.5% | >+9999.0% |
TVTX Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $333.02M(-0.1%) |
| Mar 2025 | - | $333.52M(-0.2%) |
| Dec 2024 | $334.30M(-18.5%) | $334.30M(-3.1%) |
| Sep 2024 | - | $344.83M(-16.9%) |
| Jun 2024 | - | $414.71M(-0.4%) |
| Mar 2024 | - | $416.25M(+1.5%) |
| Dec 2023 | $410.19M(-15.9%) | $410.19M(-0.8%) |
| Sep 2023 | - | $413.65M(-14.6%) |
| Jun 2023 | - | $484.23M(-0.9%) |
| Mar 2023 | - | $488.45M(+0.2%) |
| Dec 2022 | $487.57M(+39.1%) | $487.57M(-1.4%) |
| Sep 2022 | - | $494.51M(-0.8%) |
| Jun 2022 | - | $498.29M(-0.5%) |
| Mar 2022 | - | $500.79M(+42.9%) |
| Dec 2021 | $350.43M(+15.4%) | $350.43M(-1.2%) |
| Sep 2021 | - | $354.54M(+11.7%) |
| Jun 2021 | - | $317.49M(+0.4%) |
| Mar 2021 | - | $316.34M(+4.2%) |
| Dec 2020 | $303.57M(+145.0%) | $303.57M(-3.7%) |
| Sep 2020 | - | $315.38M(+8.7%) |
| Jun 2020 | - | $290.12M(+3.9%) |
| Mar 2020 | - | $279.22M(-3.1%) |
| Dec 2019 | - | $288.15M(+3.0%) |
| Sep 2019 | - | $279.84M(-0.0%) |
| Jun 2019 | - | $279.90M(+0.7%) |
| Mar 2019 | - | $277.88M(+124.3%) |
| Dec 2018 | $123.90M(+9.4%) | $123.90M(-58.3%) |
| Sep 2018 | - | $297.25M(+198.3%) |
| Jun 2018 | - | $99.66M(-31.2%) |
| Mar 2018 | - | $144.79M(+27.8%) |
| Dec 2017 | $113.28M | $113.28M(-14.2%) |
| Sep 2017 | - | $132.09M(+51.9%) |
| Jun 2017 | - | $86.93M(-1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $88.31M(-33.2%) |
| Dec 2016 | $132.11M(+62.0%) | $132.11M(+39.7%) |
| Sep 2016 | - | $94.57M(-0.9%) |
| Jun 2016 | - | $95.44M(+23.4%) |
| Mar 2016 | - | $77.32M(-6.5%) |
| Dec 2015 | $81.55M(+272.4%) | $82.73M(+10.4%) |
| Sep 2015 | - | $74.92M(+28.3%) |
| Jun 2015 | - | $58.38M(-59.8%) |
| Mar 2015 | - | $145.26M(+563.4%) |
| Dec 2014 | $21.90M(+508.1%) | $21.90M(-7.6%) |
| Sep 2014 | - | $23.69M(+0.1%) |
| Jun 2014 | - | $23.67M(+48.0%) |
| Mar 2014 | - | $15.99M(+344.2%) |
| Dec 2013 | $3.60M(>+9900.0%) | $3.60M(>+9900.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(-100.0%) |
| Mar 2013 | - | $6.96M(>+9900.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2011 | - | $0.00(0.0%) |
| Aug 2011 | - | $0.00(0.0%) |
| May 2011 | - | $0.00(0.0%) |
| Feb 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2010 | - | $0.00(0.0%) |
| Aug 2010 | - | $0.00(0.0%) |
| May 2010 | - | $0.00(0.0%) |
| Feb 2010 | $0.00(-100.0%) | $0.00(0.0%) |
| Nov 2009 | - | $0.00(-100.0%) |
| Aug 2009 | - | $10.40K(+42.5%) |
| May 2009 | - | $7300.00(+78.0%) |
| Feb 2009 | $4100.00(>+9900.0%) | $4100.00(+272.7%) |
| Nov 2008 | - | $1100.00(>+9900.0%) |
| Aug 2008 | - | $0.00(0.0%) |
| May 2008 | - | $0.00 |
| Feb 2008 | $0.00 | - |
FAQ
- What is Travere Therapeutics, Inc. annual total long term liabilities?
- What is the all time high annual long term liabilities for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. annual long term liabilities year-on-year change?
- What is Travere Therapeutics, Inc. quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. quarterly long term liabilities year-on-year change?
What is Travere Therapeutics, Inc. annual total long term liabilities?
The current annual long term liabilities of TVTX is $334.30M
What is the all time high annual long term liabilities for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high annual total long term liabilities is $487.57M
What is Travere Therapeutics, Inc. annual long term liabilities year-on-year change?
Over the past year, TVTX annual total long term liabilities has changed by -$75.90M (-18.50%)
What is Travere Therapeutics, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of TVTX is $333.02M
What is the all time high quarterly long term liabilities for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high quarterly total long term liabilities is $500.79M
What is Travere Therapeutics, Inc. quarterly long term liabilities year-on-year change?
Over the past year, TVTX quarterly total long term liabilities has changed by -$81.68M (-19.70%)